Drug establishmentActive, Registered FY2026FDA warning letter on file

Intas Pharmaceuticals Limited

Intas Pharmaceuticals Limited is an FDA-registered drug establishment (FEI 3007277149) located in . The facility is active, registered for FY2026. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Mar 30, 2026

CGMP/Finished Pharmaceuticals/Adulterated

Read the letter on FDA.gov ›

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Establishment record

FEI Number

3007277149

Address

Plot No 423/P/A, ,

Establishment type

Drug establishment

Products / operations

ANALYSIS; API MANUFACTURE; MANUFACTURE; PACK

Registration status

Active, Registered FY2026

Verify this record on FDA.gov ›

Inspection history

Inspections on file

None on file

Form 483 observations

None on file

FDA publishes only a subset of inspection records and Form 483s, so "None on file" is not a guarantee of a clean inspection history.

Questions

Is Intas Pharmaceuticals Limited registered with the FDA?

Yes. Intas Pharmaceuticals Limited is an FDA-registered drug establishment (FEI 3007277149) in . Its current registration status is Active, Registered FY2026.

Has Intas Pharmaceuticals Limited received an FDA warning letter?

Yes. FDA issued a warning letter to Intas Pharmaceuticals Limited; the most recent is dated Mar 30, 2026 (CGMP/Finished Pharmaceuticals/Adulterated).

What does Intas Pharmaceuticals Limited do?

Intas Pharmaceuticals Limited's FDA-registered operations are: ANALYSIS; API MANUFACTURE; MANUFACTURE; PACK.

Related facilities

GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD Liebel-Flarsheim Company LLC Acme United Corporation Dixon Investments Inc MERICON INDUSTRIES, INC.Scientific Protein Laboratories LLC

Source: FDA public data · status as of 2026-06-01